Brainstem proton magnetic resonance spectroscopy in idopathic REM sleep behavior disorder

Sleep

Volumn 25, Issue 8, 2002, Pages 867-870

  Iranzo, Alex ^a   Santamaria, Joan ^a   Pujol, Jesús ^b   Moreno, Angel ^b   Deus, Joan ^b   Tolosa, Eduard ^a  

^a HOSPITAL CLÍNIC   (Spain)

^b Magnetic Resonance Ctr of Pedralbes   (Spain)

Author keywords

Brainstem; REM sleep behavior disorder; Spectroscopy

Indexed keywords

CHOLINE; CREATINE KINASE; INOSITOL; N ACETYLASPARTIC ACID;

AGED; ARTICLE; BRAIN LEVEL; BRAIN METABOLISM; BRAIN STEM; CLINICAL ARTICLE; CONTROLLED STUDY; HUMAN; IDIOPATHIC DISEASE; MALE; MESENCEPHALON; NEUROLOGIC EXAMINATION; PARASOMNIA; POLYSOMNOGRAPHY; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TEGMENTUM; UNIVERSITY HOSPITAL;

EID: 0037114739     PISSN: 01618105     EISSN: None     Source Type: Journal    
DOI: 10.1093/sleep/25.8.28     Document Type: Article

References (20)

1. Mahowald MW, Schenck CH. REM sleep parasomnias. In: Kryger MH, Roth T, Dement WC, eds. Principles and Practice of Sleep Medicine. Philadelphia: W.B. Saunders Company, 2000; 724-41
2. Schenck CH, Mahowald MW. REM sleep behavior disorder: Clinical, developmental, and neuroscience perspectives 16 years after its formal identification in SLEEP. Sleep 2002; 25: 120-36
3. Schenck CH, Bundlie SR, Mahowald MH. Delayed emergence of a parkinsonian disorder in 38% of 29 older men initially diagnosed with idiopathic rapid eye movement disorder. Neurology 1996; 46: 388-93
4. Olson EJ, Boeve BF, Silber MH. Rapid eye movement sleep behaviour disorder: Demographic, clinical and laboratory findings in 93 cases. Brain 2000; 123: 331-9
5. Culebras A, Moore JT. Magnetic resonance findings in REM sleep behavior disorder. Neurology 1989; 39: 1519-23
6. Eisensher I, Linke R, Noachtar S, Schwarz J, Guildehaus FJ, Tatsch K. Reduced striatal dopamine transporters in idiopathic rapid eye movement sleep behaviour disorder. Brain 2000; 123: 1155-60
7. Albin RL, Koeppe RA, Chervin RD et al. Decreased striatal dopaminergic innervation in REM sleep behavior disorder. Neurology 2000; 55: 1410-2
8. Hendricks JC, Morrison A, Mann GL. Different behaviours during paradoxal sleep without atonia depend on pontine lesion site. Brain Res 1982; 239: 81-105
9. Ross BD, Michaelis T. Clinical applications of magnetic resonance spectroscopy. Magn Reson Q 1994; 10: 191-247
10. Cwik VA, Hanstock CC, Allen PS, Martin WR. Estimation of brainstem neuronal loss in amyotrophic lateral sclerosis with in vivo proton magnetic resonance spectroscopy. Neurology 1998; 50: 72-7
11. Mascalchi M, Tosetti M, Plasmati R, et al. Proton magnetic resonance spectroscopy in an Italian family with spinocerebellar ataxia type 1. Ann Neurol 1998; 43: 244-52
12. Lapierre O, Montplaisir J. Polysomnographic features of REM sleep behavior disorder: Development of a scoring method. Neurology 1992; 42: 1371-4
13. Schenck CH, Mahowald MW, Won Kim S, O'Oconnor KA, Hurwitz TD. Prominent eye movements during NREM sleep and REM sleep behavior disorder associated with fluoxetine treatment of depression and obsessive-compulsive disorder. Sleep 1992; 15: 226-35
14. Iranzo A, Santamaria J. Bisoprolol-induced Rapid eye movement sleep behavior disorder. Am J Med 1999; 107: 390-2
15. Kamba M, Suto Y, Ohta Y, Inoue Y, Matsuda E. Cerebral metabolism in sleep apnea. Evaluation by magnetic resonance spectroscopy. Am J Respir Crit Care Med 1997; 156: 296-8
16. Rechtschaffen A, Kales A. A Manual of Standardized Terminology, Techniques and Scoring System for Sleep Stages of Human Subjects. Los Angeles: Brain Information Service, Brain Research Institute, 1968
17. Atlas Task Force of the American Sleep Disorders Association. Guilleminault C, chairman. Recording and scoring leg movements. Sleep 1993; 16: 748-59
18. 1H-MRS). Psychiatry Clin Neurosciences 2000; 54: 350-1
19. Michaelis T, Merboldt KD, Bruhn H, Hänicke, Frahm J. Absolute concentrations of metabolites in the adult human brain in vivo: Quantification of localized proton MR spectra. Radiology 1993; 187: 219-27
20. Schenck CH, Mahowald MW. Polysomnographic, neurologic, psychiatric, and clinical outcome report on 70 consecutive cases with REM sleep behavior disorder (RBD): Sustained clonazepam efficacy in 89.5% of 57 treated patients. Clev Clin J Med 1990; 57 (Suppl): 9-23